Abstract
Snakebite is a neglected public health problem that results in significant morbidity and mortality, necessitating the World Health Organization (WHO) to develop a snakebite roadmap that aimed to halve the burden of snakebite envenoming (SBE) by 2030. This study predicted healthcare workers’ priorities regarding the WHO’s 2030 snakebite strategic key activities for preventing and controlling SBE. This cross-sectional study was conducted in the Kwahu Afram Plains North and South districts of Ghana from August to December 2024 and involved 137 healthcare workers, including physici n assistants, clinical officers, medical doctors, certificate/enrolled/general nurses, pharmacists, dispensing technicians, and community health nurses, using a multistage sampling technique. Maximum difference choice experiments and five machine learning models were used to analyze the data. Healthcare workers prioritized the activity “Making safe, effective antivenoms available, accessible, and affordable to all” as the most crucial key activity, with a utility estimate (UE) of 0.8256 (95% confidence interval (CI): 0.7300 to 0.9213), followed by “Effective first aid care and ambulance transport” (UE = 0.4348, 95% CI: 0.3266, 0.5430), “Coordinated data management and analysis” (UE = 0.3744, 95% CI: 0.2353, 0.5134), and “Promoting advocacy, effective communication, and productive engagement” (UE = 0.3630, 95% CI: 0.2528, 0.4732). The use of choice experiments and ML models has provided insights into healthcare workers’ priorities concerning the WHO’s 2030 key activities for snakebite prevention and control. This innovative approach offers a nuanced understanding of local perspectives on WHO’s key activities, which is essential for combating the burden of SBE in Ghana.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study received ethical approval from the Ghana Health Service Ethics Review Committee (GHS-ERC073/04/24) and adhered to all ethical guidelines and regulations. After explaining the purpose of the study to all participants, written informed consent was obtained. Participants were informed that their participation was voluntary and that they had the option to choose whether to participate in the study or not.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
Data will be made available on request.
